Literature DB >> 4952375

Successful estrogen therapy for post-adrenalectomy relapses of breast cancer.

J E Devitt, G E Catton.   

Abstract

Four postmenopausal women are described in whom breast cancer responded both to bilateral adrenalectomy and bilateral oophorectomy, and subsequently, after relapse, to estrogen therapy. This paradoxical finding demonstrates the complexity of the response of breast carcinoma to hormone manipulations. Simple estrogen dependence and estrogen suppression of pituitary mammotrophins are seen to be inadequate explanations of this phenomenon. Seven fundamental observations are listed that have to be accounted for by hypotheses concerning the endocrinology of breast cancer. It is suggested that in the past we have perhaps overlooked (1) the difficulty of extrapolating observations on experimental animal tumours to spontaneous human neoplasms, (2) the fact that there may be more than one type of breast cancer, and (3) the important role that must be played by the different tissues bearing the metastases.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4952375      PMCID: PMC1936600     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  11 in total

1.  OBSERVATIONS ON HORMONAL CONTROL OF MAMMARY CANCER. I. ESTROGEN AND MAMMOTROPES.

Authors:  U KIM; J FURTH; K YANNOPOULOS
Journal:  J Natl Cancer Inst       Date:  1963-08       Impact factor: 13.506

2.  A study of the epidemiology of cancer of the breast.

Authors:  E L WYNDER; I J BROSS; T HIRAYAMA
Journal:  Cancer       Date:  1960 May-Jun       Impact factor: 6.860

3.  The treatment of cancer, especially inoperable cancer, of the male breast by ablative surgery (orchiectomy, adrenalec tomy, and hypophysectomy) and hormone therapy (estrogens and corticosteroids); an analysis of 42 patients.

Authors:  N TREVES
Journal:  Cancer       Date:  1959 Jul-Aug       Impact factor: 6.860

4.  Factors influencing response to hypophysectomy for advanced cancer of breast.

Authors:  A MCCALISTER; R B WELBOURN; G J EDELSTYN; A R LYONS; A R TAYLOR; C A GLEADHILL; D S GORDON; J O COLE
Journal:  Br Med J       Date:  1961-03-04

5.  Oestrogen excretion of patients with breast cancer.

Authors:  G I SWYER; A E LEE; J P MASTERTON
Journal:  Br Med J       Date:  1961-03-04

6.  Selection of breast-cancer patients for adrenalectomy or hypophysectomy by determination of urinary 17-hydroxycorticosteroids and aetiocholanolone.

Authors:  R D BULBROOK; F C GREENWOOD; J L HAYWARD
Journal:  Lancet       Date:  1960-05-28       Impact factor: 79.321

7.  Massive estrogen administration in premenopausal women with metastatic breast cancer.

Authors:  B J KENNEDY
Journal:  Cancer       Date:  1962 May-Jun       Impact factor: 6.860

8.  Estradiol benzoate and progesterone in advanced human-breast cancer.

Authors:  R L Landau; E N Ehrlich; C Huggins
Journal:  JAMA       Date:  1962-11-10       Impact factor: 56.272

9.  Adrenalectomy and oophorectomy in metastasizing carcinoma of the breast.

Authors:  C FRANKSSON; J HELLSTROM
Journal:  Acta Chir Scand       Date:  1957-10-12

10.  BREAST CANCER AT THE ONTARIO CANCER CLINICS, 1938-1956: A STATISTICAL REVIEW.

Authors:  E N MACKAY; A H SELLERS
Journal:  Can Med Assoc J       Date:  1965-03-27       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.